Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369239
Status:
COMPLETED
Last Update Posted:
2011-05-17
First Post:
2006-08-25
Brief Title:
Treatment With Risperidone Long Acting Injectable RLAI in an Early Phase of Psychosis
Sponsor:
Janssen Pharmaceutica NV Belgium
Organization:
Janssen Pharmaceutica NV Belgium
Organization Data
Organization:
Janssen Pharmaceutica NV Belgium
Class:
INDUSTRY
Study ID:
CR002263
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Pharmaceutica NV Belgium
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None